The present invention provides a cancer vaccine composition formucosal administration for inducing cellular immunity,comprising (i) a WT1 peptide and/or a modified WT1 peptide; and(ii) a cellular immunity induction promoter. The compositionefficiently induces cellular immunity against a cancer in asubject.